Report Detail

Other Global Hospital Infection Prevention And Control Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3844534
  • |
  • 10 December, 2019
  • |
  • Global
  • |
  • 118 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Scope of the Report:
The global Hospital Infection Prevention And Control market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hospital Infection Prevention And Control.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Hospital Infection Prevention And Control market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hospital Infection Prevention And Control market by product type and applications/end industries.

Market Segment by Companies, this report covers
Cardinal Health, Inc.
Covidien plc.
Bemis Company, Inc.
Ansell Ltd.
3M Company
Belimed AG
Danaher Corp.
Cantel Medical Corp.
B. Braun Melsungen AG
Crosstex International, Inc.
Matachana Group
Sealed Air Corp.
Diversey, Inc.
Synergy Health plc.
Medivators, Inc.
Halyard Health, Inc.
Getinge Group
Semperit AG Holding
Purdue Pharma LP
Johnson & Johnson
Terumo Corp.

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Infection Prevention Supplies
Infection Prevention Equipment
Infection Prevention Services

Market Segment by Applications, can be divided into
Pneumonia
Urinary Tract Infection
Blood Stream Infection
Surgical Site Infection
MRSA


Table of Contents

    1 Hospital Infection Prevention And Control Market Overview

    • 1.1 Product Overview and Scope of Hospital Infection Prevention And Control
    • 1.2 Classification of Hospital Infection Prevention And Control by Types
      • 1.2.1 Global Hospital Infection Prevention And Control Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Hospital Infection Prevention And Control Revenue Market Share by Types in 2018
      • 1.2.3 Infection Prevention Supplies
      • 1.2.4 Infection Prevention Equipment
      • 1.2.5 Infection Prevention Services
    • 1.3 Global Hospital Infection Prevention And Control Market by Application
      • 1.3.1 Global Hospital Infection Prevention And Control Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Pneumonia
      • 1.3.3 Urinary Tract Infection
      • 1.3.4 Blood Stream Infection
      • 1.3.5 Surgical Site Infection
      • 1.3.6 MRSA
    • 1.4 Global Hospital Infection Prevention And Control Market by Regions
      • 1.4.1 Global Hospital Infection Prevention And Control Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Hospital Infection Prevention And Control Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Hospital Infection Prevention And Control Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hospital Infection Prevention And Control Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Hospital Infection Prevention And Control Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hospital Infection Prevention And Control Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Hospital Infection Prevention And Control (2014-2024)

    2 Company Profiles

    • 2.1 Cardinal Health, Inc.
      • 2.1.1 Business Overview
      • 2.1.2 Hospital Infection Prevention And Control Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Cardinal Health, Inc. Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Covidien plc.
      • 2.2.1 Business Overview
      • 2.2.2 Hospital Infection Prevention And Control Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Covidien plc. Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Bemis Company, Inc.
      • 2.3.1 Business Overview
      • 2.3.2 Hospital Infection Prevention And Control Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Bemis Company, Inc. Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Ansell Ltd.
      • 2.4.1 Business Overview
      • 2.4.2 Hospital Infection Prevention And Control Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Ansell Ltd. Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 3M Company
      • 2.5.1 Business Overview
      • 2.5.2 Hospital Infection Prevention And Control Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 3M Company Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Belimed AG
      • 2.6.1 Business Overview
      • 2.6.2 Hospital Infection Prevention And Control Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Belimed AG Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Danaher Corp.
      • 2.7.1 Business Overview
      • 2.7.2 Hospital Infection Prevention And Control Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Danaher Corp. Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Cantel Medical Corp.
      • 2.8.1 Business Overview
      • 2.8.2 Hospital Infection Prevention And Control Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Cantel Medical Corp. Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 B. Braun Melsungen AG
      • 2.9.1 Business Overview
      • 2.9.2 Hospital Infection Prevention And Control Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 B. Braun Melsungen AG Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Crosstex International, Inc.
      • 2.10.1 Business Overview
      • 2.10.2 Hospital Infection Prevention And Control Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Crosstex International, Inc. Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Matachana Group
      • 2.11.1 Business Overview
      • 2.11.2 Hospital Infection Prevention And Control Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Matachana Group Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Sealed Air Corp.
      • 2.12.1 Business Overview
      • 2.12.2 Hospital Infection Prevention And Control Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Sealed Air Corp. Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Diversey, Inc.
      • 2.13.1 Business Overview
      • 2.13.2 Hospital Infection Prevention And Control Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Diversey, Inc. Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Synergy Health plc.
      • 2.14.1 Business Overview
      • 2.14.2 Hospital Infection Prevention And Control Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Synergy Health plc. Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Medivators, Inc.
      • 2.15.1 Business Overview
      • 2.15.2 Hospital Infection Prevention And Control Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Medivators, Inc. Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 Halyard Health, Inc.
      • 2.16.1 Business Overview
      • 2.16.2 Hospital Infection Prevention And Control Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Halyard Health, Inc. Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)
    • 2.17 Getinge Group
      • 2.17.1 Business Overview
      • 2.17.2 Hospital Infection Prevention And Control Type and Applications
        • 2.17.2.1 Product A
        • 2.17.2.2 Product B
      • 2.17.3 Getinge Group Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)
    • 2.18 Semperit AG Holding
      • 2.18.1 Business Overview
      • 2.18.2 Hospital Infection Prevention And Control Type and Applications
        • 2.18.2.1 Product A
        • 2.18.2.2 Product B
      • 2.18.3 Semperit AG Holding Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)
    • 2.19 Purdue Pharma LP
      • 2.19.1 Business Overview
      • 2.19.2 Hospital Infection Prevention And Control Type and Applications
        • 2.19.2.1 Product A
        • 2.19.2.2 Product B
      • 2.19.3 Purdue Pharma LP Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)
    • 2.20 Johnson & Johnson
      • 2.20.1 Business Overview
      • 2.20.2 Hospital Infection Prevention And Control Type and Applications
        • 2.20.2.1 Product A
        • 2.20.2.2 Product B
      • 2.20.3 Johnson & Johnson Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)
    • 2.21 Terumo Corp.
      • 2.21.1 Business Overview
      • 2.21.2 Hospital Infection Prevention And Control Type and Applications
        • 2.21.2.1 Product A
        • 2.21.2.2 Product B
      • 2.21.3 Terumo Corp. Hospital Infection Prevention And Control Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Hospital Infection Prevention And Control Market Competition, by Players

    • 3.1 Global Hospital Infection Prevention And Control Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Hospital Infection Prevention And Control Players Market Share
      • 3.2.2 Top 10 Hospital Infection Prevention And Control Players Market Share
    • 3.3 Market Competition Trend

    4 Global Hospital Infection Prevention And Control Market Size by Regions

    • 4.1 Global Hospital Infection Prevention And Control Revenue and Market Share by Regions
    • 4.2 North America Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)
    • 4.5 South America Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)

    5 North America Hospital Infection Prevention And Control Revenue by Countries

    • 5.1 North America Hospital Infection Prevention And Control Revenue by Countries (2014-2019)
    • 5.2 USA Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)

    6 Europe Hospital Infection Prevention And Control Revenue by Countries

    • 6.1 Europe Hospital Infection Prevention And Control Revenue by Countries (2014-2019)
    • 6.2 Germany Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)
    • 6.3 UK Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)
    • 6.4 France Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Hospital Infection Prevention And Control Revenue by Countries

    • 7.1 Asia-Pacific Hospital Infection Prevention And Control Revenue by Countries (2014-2019)
    • 7.2 China Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)
    • 7.5 India Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)

    8 South America Hospital Infection Prevention And Control Revenue by Countries

    • 8.1 South America Hospital Infection Prevention And Control Revenue by Countries (2014-2019)
    • 8.2 Brazil Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Hospital Infection Prevention And Control by Countries

    • 9.1 Middle East and Africa Hospital Infection Prevention And Control Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Hospital Infection Prevention And Control Revenue and Growth Rate (2014-2019)

    10 Global Hospital Infection Prevention And Control Market Segment by Type

    • 10.1 Global Hospital Infection Prevention And Control Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Hospital Infection Prevention And Control Market Forecast by Type (2019-2024)
    • 10.3 Infection Prevention Supplies Revenue Growth Rate (2014-2024)
    • 10.4 Infection Prevention Equipment Revenue Growth Rate (2014-2024)
    • 10.5 Infection Prevention Services Revenue Growth Rate (2014-2024)

    11 Global Hospital Infection Prevention And Control Market Segment by Application

    • 11.1 Global Hospital Infection Prevention And Control Revenue Market Share by Application (2014-2019)
    • 11.2 Hospital Infection Prevention And Control Market Forecast by Application (2019-2024)
    • 11.3 Pneumonia Revenue Growth (2014-2019)
    • 11.4 Urinary Tract Infection Revenue Growth (2014-2019)
    • 11.5 Blood Stream Infection Revenue Growth (2014-2019)
    • 11.6 Surgical Site Infection Revenue Growth (2014-2019)
    • 11.7 MRSA Revenue Growth (2014-2019)

    12 Global Hospital Infection Prevention And Control Market Size Forecast (2019-2024)

    • 12.1 Global Hospital Infection Prevention And Control Market Size Forecast (2019-2024)
    • 12.2 Global Hospital Infection Prevention And Control Market Forecast by Regions (2019-2024)
    • 12.3 North America Hospital Infection Prevention And Control Revenue Market Forecast (2019-2024)
    • 12.4 Europe Hospital Infection Prevention And Control Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Hospital Infection Prevention And Control Revenue Market Forecast (2019-2024)
    • 12.6 South America Hospital Infection Prevention And Control Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Hospital Infection Prevention And Control Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Summary:
      Get latest Market Research Reports on Hospital Infection Prevention And Control. Industry analysis & Market Report on Hospital Infection Prevention And Control is a syndicated market report, published as Global Hospital Infection Prevention And Control Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Hospital Infection Prevention And Control market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,773.56
      4,160.34
      5,547.12
      3,232.92
      4,849.38
      6,465.84
      533,240.40
      799,860.60
      1,066,480.80
      290,371.20
      435,556.80
      580,742.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report